Reliable Data You Can Trust
Reliable Data You Can Trust
A recent report published by
Infinium Global Research on the syphilis immunoassay diagnostics market provides an in-depth analysis of segments and sub-segments in the global as well as
regional syphilis immunoassay diagnostics market. The study also highlights the
impact of drivers, restraints, and macro indicators on the global and regional
syphilis immunoassay diagnostics market over the short term as well as long
term. The report is a comprehensive presentation of trends, forecast and dollar
values of the global syphilis immunoassay diagnostics market. According to the
report, the global syphilis immunoassay diagnostics market is projected to grow
at a CAGR of 2.5% over the forecast period of 2019-2025.
Syphilis is a chronic bacterial
disease that is mostly spread through sexual activity. It can be treated with
antibiotics, especially in the early stage. According to the Centers for
Disease Control and Prevention (CDC), in 2018, a total of 35,063 cases of
primary and secondary syphilis were reported in the United States. Thereby, the
number of cases in heterosexual men and women is also increasing. In Jan 2019,
NuGenerex Diagnostics has announced that Express II Syphilis TreponemalAssay
received the CE mark. The goal of the company is to provide a response in 30
minutes with a 90 % accurate result. This will helps to drive this market.
The growing rate of anonymous sex,
sex under the influence of several drugs and the increasing number of
unprotected sex both anal and oral are the major factor contributes to the
growth of the syphilis immunoassay diagnostics market. Likewise, it is also
gaining prominence in pregnant women which results in congenital abnormalities
such as stillbirth, abortions and other abnormalities in pregnancy. This, in
turn, propelling the market. Rising incidences of fatal syphilis diseases and
disease-related high-economic burdens are anticipated to experience rapid
growth for the same market. Implementation of the provider-initiated counseling
and testing (PICT), as well as client-initiated counseling and testing (CICT)
program is the factor enhancing the market. However, the lack of skilled
professionals and the stigma associated with voluntary testing are the major
factors hindering this market. Moreover, advancements in analyzer technologies
such as PCR offers favorable opportunities in this market.
Geographically, Asia Pacific is
the region that accounts for the highest share of the syphilis immunoassay
diagnostics market. Increasing initiatives by the government and private associations
are the major contributions to the growth of the market. In addition, the
growing demand for the technologically advanced screening tests yet remains
another factor impelling the market. Thailand is the first country that has
eliminated mother-to-child transmission of syphilis and reduced transmission
rates to less than 2%. Mostly syphilis is found in developing countries with
similar trends now observed in developed nations as well. For instance, North
America is expected to grow at the highest CAGR in the forecast period.
The report on the global syphilis
immunoassay diagnostics market covers segments such as product type,
technology, and end user. On the basis of product type, the sub-markets include
analyzers, and kits and reagents. On the basis of technology, the sub-markets
include ELISA, CLIA, and other technologies. On the basis of end user, the
sub-markets include hospitals, diagnostic labs, and blood bank.
The report provides profiles of
the companies in the market such as Danaher, Bio-Rad Laboratories, Inc.,
Becton, Dickinson and Company, F. Hoffmann-La Roche Ltd, Siemens Healthineers
AG, DiaSorin S.p.A., Abbott Laboratories, Ortho Clinical Diagnostics, Shenzhen
New Industries Biomedical Engineering Co., Ltd., Gold Standard Diagnostics,
NuGenerex Diagnostics, bioMérieux SA, and Fujirebio, Inc.
The report provides deep insights
into the demand forecasts, market trends, and micro and macro indicators. In
addition, this report provides insights into the factors that are driving and
restraining the growth in this market. Moreover, The IGR-Growth Matrix analysis
given in the report brings an insight into the investment areas that existing or
new market players can consider. The report provides insights into the market
using analytical tools such as Porter's five forces analysis and DRO analysis
of syphilis immunoassay diagnostics market. Moreover, the study highlights
current market trends and provides forecast from 2019-2025. We also have
highlighted future trends in the market that will affect the demand during the
forecast period. Moreover, the competitive analysis given in each regional
market brings an insight into the market share of the leading players.
Please Choose One of them.